We are live on ! Find out more
IVAI

Index Venture Associates IV Portfolio holdings

AUM $6.24M
This Fund
S&P 500
This Quarter Est. Return
-8.26%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.37M
AUM Growth
–
Cap. Flow
+$5.71M
Cap. Flow %
77.54%
Top 10 Hldgs %
100%
Holding
1
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
NERV icon
Minerva Neurosciences
NERV
+$5.71M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NERV icon
1
Minerva Neurosciences
NERV
$185M
$7.37M 100%
+129,531
New +$5.71M

Similar funds

DG
Dumont Global New York $7.05M AUM
OCU
ORIX Corporation USA Dallas, Texas $2.31M AUM
TA
Thor Advisors New York $1.9M AUM
CC
Corsair Capital New York $1.74M AUM 5.17% 1-Year Est. Return
PP
Parplus Partners New York $343K AUM 9.29% 1-Year Est. Return
JA
JVL Advisors Houston, Texas $14.6M AUM 82.81% 1-Year Est. Return
ABC
Anchor Bolt Capital Chicago, Illinois $18M AUM 26.14% 1-Year Est. Return
CC
Caldera Capital Dallas, Texas $18.2M AUM 9.11% 1-Year Est. Return

Index Venture Associates IV's Q4 2019 Portfolio in Review

Q4 2019 is the first quarter with a 13F filing on record for Index Venture Associates IV, which disclosed 1 position worth $7.37M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Minerva Neurosciences: 129,531 shares worth $7.37M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Index Venture Associates IV's largest Q4 2019 buy was Minerva Neurosciences: 129,531 shares worth $7.37M.
  • Index Venture Associates IV's ten largest holdings make up 100% of its $7.37M portfolio in Q4 2019.
  • Index Venture Associates IV disclosed 1 position in Q4 2019, its first 13F filing on record.

Based on Index Venture Associates IV's 13F filing for Q4 2019, filed 10 Feb 2020.